Loading…
Evolent Health, Inc. is projected to rise to $7.06 by 2027, a +20% move from its current price of $5.88. EVH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.66 | $5.89 | $6.12 | +0.11% |
| Jul 14 | $5.58 | $5.89 | $6.23 | +0.22% |
| Jul 15 | $5.52 | $5.90 | $6.31 | +0.34% |
| Jul 16 | $5.47 | $5.91 | $6.38 | +0.45% |
| Jul 17 | $5.42 | $5.91 | $6.45 | +0.56% |
| Jul 18 | $5.38 | $5.92 | $6.51 | +0.67% |
| Jul 19 | $5.35 | $5.93 | $6.57 | +0.79% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.35 | $5.93 | $6.57 | +0.79% |
| Week 2 | $5.17 | $5.97 | $6.91 | +1.58% |
| Week 3 | $5.04 | $6.02 | $7.19 | +2.38% |
| Week 4 | $4.94 | $6.07 | $7.45 | +3.18% |
| Week 5 | $4.86 | $6.11 | $7.69 | +3.99% |
| Week 6 | $4.79 | $6.16 | $7.92 | +4.81% |
| Week 7 | $4.73 | $6.21 | $8.15 | +5.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolent Health, Inc. provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers an integrated value-based care platform for health plan administration and management.
It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Machinify Auth Intelligence is an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
EVH is currently priced at $5.51. It has a market cap of $619.77M and ranks 2874 by market capitalization.
The technical backdrop shows bullish sentiment with RSI14 at 70 and notable moving averages of SMA50 at $3.99 and SMA200 at $4.56.
Its 30-day range spans $4.23 to $7.18, with a support level at $3.72 and a resistance level at $5.03. The stock carries an annualized volatility of 80%.
The long-run price outlook is bullish, with the forecasted averages rising over time: 2026 avg $5.51, 2027 avg $6.51, 2028 avg $7.47, 2029 avg $8.32, 2030 avg $8.01, 2031 avg $11.17, 2032 avg $14.64, 2033 avg $15.19, 2034 avg $16.36, 2035 avg $16.65, 2040 avg $30.23, and 2050 avg $52.95.
A major floor 63.1% below — a decisive break under it would weaken the trend.
The nearest floor, 35.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 23.8% above — clearing it would confirm fresh momentum.
Key EVH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EVH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.67 | Buy | $5.69 | Buy |
| MA 10 | $5.65 | Buy | $5.55 | Buy |
| MA 20 | $5.19 | Buy | $5.24 | Buy |
| MA 50 | $4.49 | Buy | $4.59 | Buy |
| MA 100 | $3.66 | Buy | $4.28 | Buy |
| MA 200 | $4.40 | Buy | $5.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.31 | Neutral |
| Stoch RSI (14) | 61.20 | Neutral |
| CCI (20) | 100.29 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 22.50 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.24 | Buy |
| Awesome (5,34) | 0.92 | Buy |
| Ultimate (7,14,28) | 72.55 | Sell |
| Momentum (10) | 0.85 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 5.66 | Buy |
| ADX (14) | 29.86 | Buy |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is bullish, supported by an RSI of 70.
Key moving averages are SMA50 at $3.99 and SMA200 at $4.56, providing nearby dynamics for near-term price action.
The 30-day range is $4.23–$7.18, with a nearby support at $3.72 and a resistance at $5.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.17 | $5.88 | $8.62 | 0% | Neutral | |
| $5.40 | $7.06 | $9.88 | +20% | Bullish | |
| $5.86 | $7.99 | $11.75 | +36% | Bullish | |
| $6.37 | $8.98 | $13.73 | +53% | Bullish | |
| $6.22 | $9.05 | $14.28 | +54% | Bullish | |
| $8.01 | $12.00 | $19.47 | +104% | Bullish | |
| $10.25 | $15.78 | $26.24 | +168% | Bullish | |
| $10.88 | $17.18 | $29.21 | +192% | Bullish | |
| $11.04 | $17.86 | $30.99 | +204% | Bullish | |
| $10.97 | $18.17 | $32.14 | +209% | Bullish | |
| $17.88 | $33.06 | $63.21 | +462% | Bullish | |
| $26.93 | $59.84 | $127.94 | +918% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.17 | $5.88 | $7.14 | +0.00% |
| August 2026 | $5.22 | $6.24 | $7.70 | +6.09% |
| September 2026 | $5.40 | $6.51 | $8.16 | +4.38% |
| October 2026 | $5.26 | $6.40 | $8.13 | -1.65% |
| November 2026 | $5.20 | $6.37 | $8.18 | -0.48% |
| December 2026 | $5.39 | $6.65 | $8.62 | +4.30% |
Click any year to see its month-by-month EVH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The EVH price prediction for 2026 points to an average of $5.88 (low $2.17, high $8.62) — a potential gain of 0% on today's $5.88. Price action looks broadly range-bound.
In 2027, EVH is projected to trade between $5.40 and $9.88, averaging $7.06 — a potential gain of +20% from today's $5.88. That is up +20% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Evolent Health, Inc.'s 2028 outlook centres on $7.99, within a $5.86 to $11.75 range. That is up +13% on the projected 2027 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2029, EVH could reach as high as $13.73, with a base case around $8.98 and support toward $6.37 — roughly +53% from $5.88. Buyers look set to stay in control over this stretch.
Expect EVH to range from $6.22 to $14.28 through 2030. The $9.05 average target implies a +54% move from current prices. That is up +1% on the projected 2029 average. Momentum favours further upside here.
The EVH price prediction for 2031 points to an average of $12.00 (low $8.01, high $19.47) — a potential gain of +104% on today's $5.88. Buyers look set to stay in control over this stretch.
In 2032, EVH is projected to trade between $10.25 and $26.24, averaging $15.78 — a potential gain of +168% from today's $5.88. That is up +32% on the projected 2031 average. Momentum favours further upside here.
Evolent Health, Inc.'s 2033 outlook centres on $17.18, within a $10.88 to $29.21 range. That is up +9% on the projected 2032 average. That marks a +192% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, EVH could reach as high as $30.99, with a base case around $17.86 and support toward $11.04 — roughly +204% from $5.88. Momentum favours further upside here.
Expect EVH to range from $10.97 to $32.14 through 2035. The $18.17 average target implies a +209% move from current prices. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The EVH price prediction for 2040 points to an average of $33.06 (low $17.88, high $63.21) — a potential gain of +462% on today's $5.88. Momentum favours further upside here.
In 2050, EVH is projected to trade between $26.93 and $127.94, averaging $59.84 — a potential gain of +918% from today's $5.88. That is up +81% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in EVH today (≈ 170.068027 EVH) could be worth
$10,177.41
+$9,177.41 (+918%) by 2050 · US Dollar
Based on the average projected EVH price of $59.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EVHwould be worth at today's price.
$1,000 invested in EVH on Jul 10, 2025 (≈ 89.047199 EVH) would be worth
$523.6
-$476.4 (-47.6%) today · 0.52× · US Dollar
Based on a EVH entry price of $11.23 vs. today's $5.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.71 | $1,029.77 | +3.0% |
| 1 month ago | $4.47 | $1,315.44 | +31.5% |
| 3 months ago | $2.33 | $2,523.61 | +152.4% |
| 6 months ago | $4.15 | $1,416.87 | +41.7% |
| 1 year ago | $11.23 | $523.6 | -47.6% |
| All time (5.0y) ago | $22.26 | $264.15 | -73.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EVH forecast.
Our base-case forecast reaches $12.00 around 2032.
Implied market cap at $12.00: $1.35B
The multi-year forecast shows a bullish trajectory beyond 2026, with the 2030 average price projected at $8.01 and a 45.4 as the ROI figure. The sentiment for 2030 is BULLISH.
In 2040 the average price is forecast at $30.23 with a 448.7 ROI and a BULLISH sentiment, highlighting substantial long-term upside.
By 2050 the average price is forecast at $52.95 with an 861 ROI and a BULLISH sentiment, indicating a continued and pronounced upward trajectory over the horizon.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $5.44, an avg of $8.01, and a max of $12.78, with an ROI of 45.4 and sentiment BULLISH.
The forecast exhibits a bullish trajectory across multiple years, with rising averages and positive ROIs in 2027 (18.1), 2028 (35.5), 2029 (51), 2030 (45.4), 2031 (102.6), 2032 (165.7), 2033 (175.8), 2034 (196.8), 2035 (202.1), and strong upside continuing to 2040 (448.7) and 2050 (861). The 2026 year is neutral with ROI 0.
Yes. The 2040 max is $58.69 and the 2050 max is $115.18, while the 2050 average price is $52.95.
Current price is $5.51 and market cap is $619.77M. The asset ranks 2874 by market cap.
The 30-day range is $4.23 to $7.18.
Evolent Health, Inc. Community Discussion
0Share your Evolent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.